In our study, the absolute counts of HLA-DR+ exhibited no causal relationship with the risk of ALS; nonetheless, a higher expression level of CD16–CD56+ was associated with a lower risk of ALS. The gene discussed is NCAM1; the disease is amyotrophic lateral sclerosis.